Life Science
Public Biotech Makes Up Just 1.1% of Alexandria’s Q3 Leasing as Seattle’s Pipeline Thins
Publicly traded biotech companies accounted for only 1.1 percent of the 1.24 million square feet Alexandria Real Estate Equities leased in the third...
Lumen Bioscience Leases 39,000 SQFT at Lake Union Center in Seattle’s Wallingford as Lab Vacancy Hits 18.9%
Seattle biologics developer Lumen Bioscience landed the largest notable life sciences lease in the Seattle market in the third quarter, a 39,000-square-foot deal...
Alexandria’s Seattle Pivot Holds as Q3 Write-Downs Hit Palo Alto, San Carlos and Austin Instead
Alexandria Real Estate Equities' third-quarter results show its Seattle strategy of converting surplus lab sites to housing and courting advanced technology tenants still...
Alexandria CEO Says Institutional Investors Still Favor Seattle Lab Buildings Despite 18.9% Vacancy
Peter Moglia, chief executive of Alexandria Real Estate Equities, told analysts that Seattle belongs with Boston, San Francisco and San Diego as a...
Alexandria Swings to $638.5MM Loss on Write-Downs as CEO Ranks Seattle Among Investors’ Favored Lab Markets
Alexandria Real Estate Equities booked $637.9 million of real estate impairments in the third quarter and swung to a $638.5 million net loss,...
Seattle Lab Pipeline Goes Dark With Zero Construction, Leaving 1.8MM SQFT to Absorb
Seattle has no life science space under construction, and San Diego has joined it at zero while the Bay Area’s pipeline shrank to...
Seattle Life Science VC Plunges 58% to $396MM as Bay Area Funding Holds at $8.3B
Seattle life science companies raised only $395.9 million through the third quarter, on pace for the weakest year since at least 2022, as...
Seattle NIH Funding Slips to $1.2B as Federal Budget Fights Test Research Lab Landlords
National Institutes of Health funding to Seattle-area researchers slipped to $1.2 billion in the fiscal year that ended Sept. 30, part of a...
Genentech Breaks Ground on $750MM, 211,000 SQFT Manufacturing Expansion in Hillsboro
Genentech broke ground on a $750MM, 211,000 SF expansion in Hillsboro that will add device fill-finish manufacturing and 250 jobs by 2031.
Alexandria Stretches $5B Credit Line to 2032 as Seattle Lab Sites Pivot to Housing and Tech
Alexandria Real Estate Equities extended its $5 billion revolving credit facility to 2032 at a lower spread, a refinancing that buys runway for...
Seattle Life Science Stays Tightest of West Coast Hubs as New Construction Halts
Seattle's life science market entered the second half of 2026 with the lowest vacancy of any major West Coast hub and no space...
Breakthrough Properties Acquires Stalled Seagen Biologics Plant in Everett for $78MM
A biomanufacturing facility that Pfizer abandoned two years into a $500 million build-out has changed hands for a fraction of that investment, landing...
